Immix Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2024 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Immix Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2024 to Q2 2024.
  • Immix Biopharma, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending June 30, 2024 was $1.6M.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.6M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.62M Mar 31, 2024 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.